Trial
NCT06304883
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alzheon Inc.
Collaborators
—
Condition
Early Alzheimer's Disease
Intervention
Experimental: ALZ-801
Why stopped
Sponsor business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-25